Helicobacter pylori growth medium is usually supplemented with horse serum (HS) or FCS. However, cyclodextrin derivatives or activated charcoal can replace serum. In this study, we purified self-growth-inhibiting (SGI) compounds from H. pylori growth medium. The compounds were recovered from porous resin, Diaion HP-20, which was added to the H. pylori growth medium instead of known supplements. These SGI compounds were also identified from 2,6-di-O-methyl-β-cyclodextrin, which was supplemented in a pleuropneumonia-like organisms broth. The growth-inhibiting compounds were identified as lauric acid (LA) and 7-(Z)-tetradecenoic acid [7-(Z)-TDA]. Although several fatty acids had been identified in H. pylori, these specific compounds were not previously found in this species. However, we confirmed that these fatty acids were universally present in the cultivation medium of the H. pylori strains examined in this study. A live/dead assay carried out without HS indicated that these compounds were bacteriostatic; however, no significant growth-inhibiting effect was observed against other tested bacterial species that constituted the indigenous bacterial flora. These findings suggested that LA and 7-(Z)-TDA might play important roles in the survival of H. pylori in human stomach epithelial cells.
BarberC. E.,
TangJ. L.,
FengJ. X.,
PanM. Q.,
WilsonT. J. G.,
SlaterH.,
DowJ. M.,
WilliamsP.,
DanielsM. J.
(1997). A novel regulatory system required for pathogenicity of Xanthomonas campestris is mediated by a small diffusible signal molecule. Mol Microbiol24, 555–566.[CrossRef][Google Scholar]
BatchelorJ. G.,
CronanJ. E.Jr
(1973). Occurrence of cis-7-tetradecenoic acid in the envelope phospholipids of Escherichia coli K12. Biochem Biophys Res Commun52, 1374–1380.[CrossRef][Google Scholar]
BeaulieuE. D.,
IonescuM.,
ChatterjeeS.,
YokotaK.,
TraunerD.,
LindowS.
(2013). Characterization of a diffusible signaling factor from Xylella fastidiosa. MBio4, e00539-12.[CrossRef][Google Scholar]
BrownL. M.
(2000). Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev22, 283–297.[CrossRef][Google Scholar]
BuckG. E.,
SmithJ. S.
(1987). Medium supplementation for growth of Campylobacter pyloridis. J Clin Microbiol25, 597–599.
[Google Scholar]
CaveD. R.
(1997). How is Helicobacter pylori transmitted?Gastroenterology113 (Suppl), S9–S14.[CrossRef][Google Scholar]
CorreiaM.,
MichelV.,
MatosA. A.,
CarvalhoP.,
OliveiraM. J.,
FerreiraR. M.,
DilliesM. -A.,
HuerreM.,
SerucaR.,
other authors.
(2012). Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization. PLoS One7, e35072.[CrossRef][Google Scholar]
CorreiaM.,
MichelV.,
OsórioH.,
El GhachiM.,
BonisM.,
BonecaI. G.,
De ReuseH.,
MatosA. A.,
LenormandP.,
other authors.
(2013). Crosstalk between Helicobacter pylori and gastric epithelial cells is impaired by docosahexaenoic acid. PLoS One8, e60657.[CrossRef][Google Scholar]
CorreiaM.,
CasalS.,
VinagreJ.,
SerucaR.,
FigueiredoC.,
TouatiE.,
MachadoJ. C.
(2014). Helicobacter pylori's cholesterol uptake impacts resistance to docosahexaenoic acid. Int J Med Microbiol304, 314–320.[CrossRef][Google Scholar]
CoudronP. E.,
StrattonC. W.
(1995). Factors affecting growth and susceptibility testing of Helicobacter pylori in liquid media. J Clin Microbiol33, 1028–1030.
[Google Scholar]
EdelsteinP. H.,
EdelsteinM. A.
(1993). Comparison of three buffers used in the formulation of buffered charcoal yeast extract medium. J Clin Microbiol31, 3329–3330.
[Google Scholar]
FerreroR. L.,
CussacV.,
CourcouxP.,
LabigneA.
(1992). Construction of isogenic urease-negative mutants of Helicobacter pylori by allelic exchange. J Bacteriol174, 4212–4217.
[Google Scholar]
ForsythM. H.,
CoverT. L.
(2000). Intercellular communication in Helicobacter pylori: luxS is essential for the production of an extracellular signaling molecule. Infect Immun68, 3193–3199.[CrossRef][Google Scholar]
GarrenM.,
AzamF.
(2010). New method for counting bacteria associated with coral mucus. Appl Environ Microbiol76, 6128–6133.[CrossRef][Google Scholar]
GeisG.,
LeyingH.,
SuerbaumS.,
OpferkuchW.
(1990). Unusual fatty acid substitution in lipids and lipopolysaccharides of Helicobacter pylori. J Clin Microbiol28, 930–932.
[Google Scholar]
GoodwinC. S.,
MendallM. M.,
NorthfieldT. C.
(1997). Helicobacter pylori infection. Lancet349, 265–269.[CrossRef][Google Scholar]
HazellS. L.,
GrahamD. Y.
(1990). Unsaturated fatty acids and viability of Helicobacter (Campylobacter) pylori. J Clin Microbiol28, 1060–1061.
[Google Scholar]
InoueH.,
KawanoG.,
NagasawaH.,
SakudaS.
(2002). Isolation of elemental sulfur as a self-growth-inhibiting substance produced by Legionella pneumophila. Appl Environ Microbiol68, 4809–4811.[CrossRef][Google Scholar]
Jiménez-SotoL. F.,
RohrerS.,
JainU.,
ErtlC.,
SewaldX.,
HaasR.
(2012). Effects of cholesterol on Helicobacter pylori growth and virulence properties in vitro. Helicobacter17, 133–139.[CrossRef][Google Scholar]
JoyceE. A.,
BasslerB. L.,
WrightA.
(2000). Evidence for a signaling system in Helicobacter pylori: detection of a luxS-encoded autoinducer. J Bacteriol182, 3638–3643.[CrossRef][Google Scholar]
KabaraJ. J.,
SwieczkowskiD. M.,
ConleyA. J.,
TruantJ. P.
(1972). Fatty acids and derivatives as antimicrobial agents. Antimicrob Agents Chemother2, 23–28.[CrossRef][Google Scholar]
KaritaM.,
KouchiyamaT.,
OkitaK.,
NakazawaT.
(1991). New small animal model for human gastric Helicobacter pylori infection: success in both nude and euthymic mice. Am J Gastroenterol86, 1596–1603.
[Google Scholar]
KnappH. R.,
MellyM. A.
(1986). Bactericidal effects of polyunsaturated fatty acids. J Infect Dis84–94, 101093/infdis/154184.
[Google Scholar]
KovalevaA. S.,
BulinaV. M.,
IvanovL. L.,
PyatnovaYu. B.,
EvstigneevaR. P.
(1974). Use of the Wittig reaction in the synthesis of unsaturated alcohol acetates. Z Organ Khim10, 696–700, (in Russian).
[Google Scholar]
MarshallB. J.
(1994). Helicobacter pylori. Am J Gastroenterol89 (Suppl.8), 116–128.
[Google Scholar]
MorganD. R.,
FreedmanR.,
DepewC. E.,
KraftW. G.
(1987). Growth of Campylobacter pylori in liquid media. J Clin Microbiol25, 2123–2125.
[Google Scholar]
NCCLS (1990). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Publication M7-A2, 2nd edn.Villanova, PA: National Committee for Clinical Laboratory Standards
[Google Scholar]
NiemanC.
(1954). Influence of trace amounts of fatty acids on the growth of microorganisms. Bacteriol Rev18, 147–163.
[Google Scholar]
NomuraA.,
StemmermannG. N.,
ChyouP. H.,
Perez-PerezG. I.,
BlaserM. J.
(1994). Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med120, 977–981.[CrossRef][Google Scholar]
OcchialiniA.,
MaraisA.,
AlmR.,
GarciaF.,
SierraR.,
MégraudF.
(2000). Distribution of open reading frames of plasticity region of strain J99 in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect Immun68, 6240–6249.[CrossRef][Google Scholar]
OlivieriR.,
BugnoliM.,
ArmelliniD.,
BianciardiS.,
RappuoliR.,
BayeliP. F.,
AbateL.,
EspositoE.,
de GregorioL.,
other authors.
(1993). Growth of Helicobacter pylori in media containing cyclodextrins. J Clin Microbiol31, 160–162.
[Google Scholar]
PetschowB. W.,
BatemaR. P.,
FordL. L.
(1996). Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids. Antimicrob Agents Chemother40, 302–306.
[Google Scholar]
ShimomuraH.,
HosodaK.,
HayashiS.,
YokotaK.,
OgumaK.,
HiraiY.
(2009). Steroids mediate resistance to the bactericidal effect of phosphatidylcholines against Helicobacter pylori. FEMS Microbiol Lett301, 84–94.[CrossRef][Google Scholar]
SunC. Q.,
O'ConnorC. J.,
RobertonA. M.
(2003). Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori. FEMS Immunol Med Microbiol36, 9–17.[CrossRef][Google Scholar]
TanakaR.,
KunisadaT.,
KushidaN.,
YamadaK.,
IkedaS.,
NoikeM.,
OnoY.,
ItohN.,
TakamiH.,
other authors.
(2011). Branched fatty acids inhibit the biosynthesis of menaquinone in Helicobacter pylori. J Antibiot (Tokyo)64, 151–153.[CrossRef][Google Scholar]
TaneeraJ.,
MoranA. P.,
HynesS. O.,
NilssonH. O.,
Al-SoudWa.,
WadströmT.
(2002). Influence of activated charcoal, porcine gastric mucin and β-cyclodextrin on the morphology and growth of intestinal and gastric Helicobacter spp. Microbiology148, 677–684.
[Google Scholar]
ThompsonL.,
CockayneA.,
SpillerR. C.
(1994). Inhibitory effect of polyunsaturated fatty acids on the growth of Helicobacter pylori: a possible explanation of the effect of diet on peptic ulceration. Gut35, 1557–1561.[CrossRef][Google Scholar]
WangL. H.,
HeY.,
GaoY.,
WuJ. E.,
DongY. H.,
HeC.,
WangS. X.,
WengL. X.,
XuJ. L.,
other authors.
(2004). A bacterial cell–cell communication signal with cross-kingdom structural analogues. Mol Microbiol51, 903–912.[CrossRef][Google Scholar]
WarrenJ. R.,
MarshallB. J.
(1983). Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet1, 1273–1275.
[Google Scholar]